Therapy Areas: Devices
SeaStar Medical earns FDA Breakthrough Device Designation for Selective Cytopheretic Device in cardiorenal syndrome
29 September 2023 - Medical device company SeaStar Medical Holding Corporation (Nasdaq:ICU) announced on Friday that it has secured Breakthrough Device Designation from the US Food and Drug Administra...
Nevro highlights cost savings with 10 kHz spinal cord stimulation therapy
18 September 2023 - Medical device company Nevro Corp. (NYSE: NVRO), that specialises in chronic pain treatment, on Monday released new data showcasing the cost-effectiveness of its proprietary 10 kHz...
Telix Pharmaceuticals to present ZIRCON Phase III kidney cancer imaging data and theranostic pipeline at EANM Congress
6 September 2023 - Biopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX) reported on Wednesday that it will showcase its theranostic programs at the 36th Annual Congress of the European A...
Arecor Therapeutics announces commercialisation agreement between Tetris Pharma and Goodlife for Ogluo in BeNeLux
4 September 2023 - Biopharmaceutical group Arecor Therapeutics plc (AIM: AREC) reported on Monday that its subsidiary Tetris Pharma Ltd has established an exclusive commercialisation agreement with pr...
Attune Medical partners with Gentherm for thermal regulating technology
30 August 2023 - Attune Medical and Gentherm (NASDAQ: THRM) on Wednesday announced a non-exclusive distribution agreement, offering healthcare providers a bundled disposable purchase option for Genthe...
Belluscura signs USD55m Exclusive License deal for proprietary oxygen technology in China
30 August 2023 - Medical device developer Belluscura plc (AIM: BELL) announced on Wednesday that it has entered a groundbreaking Exclusive License, Marketing and Distribution Agreement with InnoMax Me...